205.05
+0.90
+(0.44%)
As of 8:25:15 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 16 | 16 | 20 | 20 |
Avg. Estimate | 6.12B | 6.39B | 25.62B | 27.03B |
Low Estimate | 5.79B | 6.22B | 24.99B | 26.14B |
High Estimate | 6.23B | 6.47B | 25.92B | 27.58B |
Year Ago Sales | 5.16B | 5.4B | 22.06B | 25.62B |
Sales Growth (year/est) | 18.70% | 18.24% | 16.13% | 5.51% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
UWS.F | -- | -- | -- | -- |
S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
Maintains | Scotiabank: Sector Outperform to Sector Outperform | 4/8/2025 |
Maintains | CIBC: Neutral to Neutral | 3/5/2025 |
Maintains | Citigroup: Buy to Buy | 2/3/2025 |
Maintains | Scotiabank: Sector Outperform to Sector Outperform | 2/3/2025 |
Maintains | Oppenheimer: Outperform to Outperform | 1/31/2025 |
Maintains | Raymond James: Outperform to Outperform | 1/31/2025 |